4,102
Views
136
CrossRef citations to date
0
Altmetric
Review Article

Coffee components and cardiovascular risk: beneficial and detrimental effects

, , , , , & show all
Pages 925-936 | Received 29 Apr 2014, Accepted 25 Jun 2014, Published online: 21 Jul 2014

References

  • Abrahao SA, Pereira RG, de Sousa RV, Lima AR, Crema GP, Barros BS. 2013. Influence of coffee brew in metabolic syndrome and type 2 diabetes. Plant Foods Hum Nutr 68:184–189
  • Actis-Goretta L, Ottaviani JI, Fraga CG. 2006. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem 54:229–234
  • Adisakwattana S, Chantarasinlapin P, Thammarat H, Yibchok-Anun S. 2009. A series of cinnamic acid derivatives and their inhibitory activity on intestinal alpha-glucosidase. J Enzyme Inhib Med Chem 24:1194–1200
  • Ammon HP, Bieck PR, Mandalaz D, Verspohl EJ. 1983. Adaptation of blood pressure to continuous heavy coffee drinking in young volunteers. A double-blind crossover study. Br J Clin Pharmacol 15:701–706
  • Andrade-Cetto A, Wiedenfeld H. 2001. Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats. J Ethnopharmacol 78:145–149
  • Ardiansyah, Ohsaki Y, Shirakawa H, Koseki T, Komai M. 2008. Novel effects of a single administration of ferulic acid on the regulation of blood pressure and the hepatic lipid metabolic profile in stroke-prone spontaneously hypertensive rats. J Agric Food Chem 56:2825–2830
  • Arion WJ, Canfield WK, Ramos FC, Schindler PW, Burger HJ, Hemmerle H, Schubert G, et al. 1997. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys 339:315–322
  • Bakuradze T, Lang R, Hofmann T, Stiebitz H, Bytof G, Lantz I, Baum M, et al. 2010. Antioxidant effectiveness of coffee extracts and selected constituents in cell-free systems and human colon cell lines. Mol Nutr Food Res 54:1734–1743
  • Bassoli BK, Cassolla P, Borba-Murad GR, Constantin J, Salgueiro-Pagadigorria CL, Bazotte RB, da Silva RS, de Souza HM. 2008. Chlorogenic acid reduces the plasma glucose peak in the oral glucose tolerance test: effects on hepatic glucose release and glycaemia. Cell Biochem Funct 26:320–328
  • Belitz H-D, Grosch W, Schieberle P. 2009. Food chemistry. In: Belitz H-D, Grosch W, Schieberle P, editors. Coffee, tea, cocoa. Berlin: Springer. p 938–951
  • Benowitz NL. 1990. Clinical pharmacology of caffeine. Annu Rev Med 41:277–288
  • Borrelli RC, Visconti A, Mennella C, Anese M, Fogliano V. 2002. Chemical characterization and antioxidant properties of coffee melanoidins. J Agric Food Chem 50:6527–6533
  • Buscemi S, Verga S, Batsis JA, Donatelli M, Tranchina MR, Belmonte S, Mattina A, et al. 2010. Acute effects of coffee on endothelial function in healthy subjects. Eur J Clin Nutr 64:483–489
  • Buscemi S, Verga S, Batsis JA, Tranchina MR, Belmonte S, Mattina A, Re A, et al. 2009. Dose-dependent effects of decaffeinated coffee on endothelial function in healthy subjects. Eur J Clin Nutr 63:1200–1205
  • Butt MS, Sultan MT. 2011. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr 51:363–373
  • Cagliani LR, Pellegrino G, Giugno G, Consonni R. 2013. Quantification of Coffea arabica and Coffea canephora var. robusta in roasted and ground coffee blends. Talanta 106:169–173
  • Calani L, Dall'Asta M, Derlindati E, Scazzina F, Bruni R, Del Rio D. 2012. Colonic metabolism of polyphenols from coffee, green tea, and hazelnut skins. J Clin Gastroenterol 46:S95–S99
  • Campa C, Doulbeau S, Dussert S, Hamon S, Noirot M. 2005. Qualitative relationship between caffeine and chlorogenic acid contents among wild Coffea species. Food Chem 93:135–139
  • Caprioli G, Cortese M, Maggi F, Minnetti C, Odello L, Sagratini G, Vittori S. 2014. Quantification of caffeine, trigonelline and nicotinic acid in espresso coffee: the influence of espresso machines and coffee cultivars. Int J Food Sci Nutr 65:465–469
  • Carrillo JA, Benitez J. 2000. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 39:127–153
  • Carvalho Ddo C, Brigagao MR, dos Santos MH, de Paula FB, Giusti-Paiva A, Azevedo L. 2011. Organic and conventional Coffea arabica L.: a comparative study of the chemical composition and physiological, biochemical and toxicological effects in Wistar rats. Plant Foods Hum Nutr 66:114–121
  • Clifford MN. 1999. Chlorogenic acids and other cinnamates – nature occurrence and dietary burden. J Sci Food Agric 79:362–372
  • Correa TA, Monteiro MP, Mendes TM, Oliveira DM, Rogero MM, Benites CI, Vinagre CG, et al. 2012. Medium light and medium roast paper-filtered coffee increased antioxidant capacity in healthy volunteers: results of a randomized trial. Plant Foods Hum Nutr 67:277–282
  • Corti R, Binggeli C, Sudano I, Spieker L, Hanseler E, Ruschitzka F, Chaplin WF, et al. 2002. Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking. Circulation 106:2935–2940
  • Crews HM, Olivier L, Wilson LA. 2001. Urinary biomarkers for assessing dietary exposure to caffeine. Food Addit Contam 18:1075–1087
  • Crozier TW, Stalmach A, Lean ME, Crozier A. 2012. Espresso coffees, caffeine and chlorogenic acid intake: potential health implications. Food Funct 3:30–33
  • Daglia M, Papetti A, Aceti C, Sordelli B, Gregotti C, Gazzani G. 2008. Isolation of high molecular weight components and contribution to the protective activity of coffee against lipid peroxidation in a rat liver microsome system. J Agric Food Chem 56:11653–11660
  • Daglia M, Papetti A, Gregotti C, Berte F, Gazzani G. 2000. In vitro antioxidant and ex vivo protective activities of green and roasted coffee. J Agric Food Chem 48:1449–1454
  • Dall'Asta M, Calani L, Tedeschi M, Jechiu L, Brighenti F, Del Rio D. 2012. Identification of microbial metabolites derived from in vitro fecal fermentation of different polyphenolic food sources. Nutrition 28:197–203
  • Daly JW. 1993. Mechanism of action of caffeine. In: Garattini S, editor. Caffeine, coffee, and health. New York: Raven Press Ltd. p 97–150
  • De Marco LM, Fischer S, Henle T. 2011. High molecular weight coffee melanoidins are inhibitors for matrix metalloproteases. J Agric Food Chem 59:11417–11423
  • De Roos B, Meyboom S, Kosmeijer-Schuil TG, Katan MB. 1998. Absorption and urinary excretion of the coffee diterpenes cafestol and kahweol in healthy ileostomy volunteers. J Intern Med 244:451–460
  • Del Rio D, Stalmach A, Calani L, Crozier A. 2010. Bioavailability of coffee chlorogenic acids and green tea flavan-3-ols. Nutrients 2:820–833
  • Delgado-Andrade C, Morales FJ. 2005. Unraveling the contribution of melanoidins to the antioxidant activity of coffee brews. J Agric Food Chem 53:1403–1407
  • Delgado-Andrade C, Rufian-Henares JA, Morales FJ. 2005. Assessing the antioxidant activity of melanoidins from coffee brews by different antioxidant methods. J Agric Food Chem 53:7832–7836
  • dos Santos MD, Almeida MC, Lopes NP, de Souza GE. 2006. Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol Pharm Bull 29:2236–2240
  • Esposito F, Morisco F, Verde V, Ritieni A, Alezio A, Caporaso N, Fogliano V. 2003. Moderate coffee consumption increases plasma glutathione but not homocysteine in healthy subjects. Aliment Pharmacol Ther 17:595–601
  • Fisone G, Borgkvist A, Usiello A. 2004. Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci 61:857–872
  • Fogliano V, Morales FJ. 2011. Estimation of dietary intake of melanoidins from coffee and bread. Food Funct 2:117–123
  • Fujioka K, Shibamoto T. 2008. Chlorogenic acid and caffeine contents in various commercial brewed coffees. Food Chem 106:217–221
  • Funke I, Melzig MF. 2005. Effect of different phenolic compounds on alpha-amylase activity: screening by microplate-reader based kinetic assay. Pharmazie 60:796–797
  • Geraets L, Moonen HJ, Wouters EF, Bast A, Hageman GJ. 2006. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations. Biochem Pharmacol 72:902–910
  • Gniechwitz D, Reichardt N, Ralph J, Blaut M, Steinhart H, Bunzel M. 2008. Isolation and characterisation of a coffee melanoidin fraction. J Sci Food Agric 88:2153–2160
  • Goldstein JL, Brown MS. 1977. Atherosclerosis: the low-density lipoprotein receptor hypothesis. Metabolism 26:1257–1275
  • Grigg D. 2003. The worlds of tea and coffee: patterns of consumption. Geo J 57:283–294
  • Gross G, Jaccaud E, Huggett AC. 1997. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem Toxicol 35:547–554
  • Grosso G, Marventano S, Galvano F, Pajak A, Mistretta A. 2014. Factors associated with metabolic syndrome in a Mediterranean population: role of caffeinated beverages. J Epidemiol 24:327–333
  • Guillet C. 2010. Implication des produits terminaux de glycation dans les complications liées au diabète. Nutrition Clinique et Métabolisme 24:109–114
  • Gulcin I. 2012. Antioxidant activity of food constituents: an overview. Arch Toxicol 86:345–391
  • Halliwell B, Long LH, Yee TP, Lim S, Kelly R. 2004. Establishing biomarkers of oxidative stress: the measurement of hydrogen peroxide in human urine. Curr Med Chem 11:1085–1092
  • Halvorsen BL, Carlsen MH, Phillips KM, Bohn SK, Holte K, Jacobs DR, Jr Blomhoff R. 2006. Content of redox-active compounds (i.e., antioxidants) in foods consumed in the United States. Am J Clin Nutr 84:95–135
  • Herling AW, Burger HJ, Schwab D, Hemmerle H, Below P, Schubert G. 1998. Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system. Am J Physiol 274:G1087–G1093
  • Hernández-Ledesma B, Martín-Álvarez PJ, Pueyo E. 2003. Assessment of the spectrophotometric method for determination of angiotensin-converting-enzyme activity: influence of the inhibition type. J Agric Food Chem 51:4175–4179
  • Imig JD. 2004. ACE Inhibition and bradykinin-mediated renal vascular responses: EDHF involvement. Hypertension 43:533–535
  • Ishikawa A, Yamashita H, Hiemori M, Inagaki E, Kimoto M, Okamoto M, Tsuji H, et al. 2007. Characterization of inhibitors of postprandial hyperglycemia from the leaves of Nerium indicum. J Nutr Sci Vitaminol (Tokyo) 53:166–173
  • Miners JO, McKinnon RA. 2000. CYP1A. In: Levy RH, Thummel KE, Trager WF, Hansten PD, Eichelbaum ME, editors. Metabolic drug interactions. New York (NY): Lippincott Williams & Wilkins. p 61–73
  • Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ. 2001. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 153:353–362
  • Jiang X, Zhang D, Jiang W. 2014. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr 53:25–38
  • Jin UH, Lee JY, Kang SK, Kim JK, Park WH, Kim JG, Moon SK, Kim CH. 2005. A phenolic compound, 5-caffeoylquinic acid (chlorogenic acid), is a new type and strong matrix metalloproteinase-9 inhibitor: isolation and identification from methanol extract of Euonymus alatus. Life Sci 77:2760–2769
  • Karthikesan K, Pari L, Menon VP. 2010. Antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents. Chem Biol Interact 188:643–650
  • Kolling-Speer I, Strohschneider S, Speer K. 1999. Determination of free diterpenes in green and roasted coffees. J High Resolut Chromatogr 22:43–46
  • Kozuma K, Tsuchiya S, Kohori J, Hase T, Tokimitsu I. 2005. Antihypertensive effect of green coffee bean extract on mildly hypertensive subjects. Hypertens Res 28:711–718
  • Krakauer T. 2002. The polyphenol chlorogenic acid inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines. Immunopharmacol Immunotoxicol 24:113–119
  • Krul C, Hageman G. 1998. Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 709:27–34
  • Kurzrock T, Speer K. 2011. Diterpenes and diterpene esters in coffee. Food Rev Int 17:433–450
  • Lang R, Dieminger N, Beusch A, Lee YM, Dunkel A, Suess B, Skurk T, et al. 2013. Bioappearance and pharmacokinetics of bioactives upon coffee consumption. Anal Bioanal Chem 405:8487–8503
  • Laranjinha JA, Almeida LM, Madeira VM. 1994. Reactivity of dietary phenolic acids with peroxyl radicals: antioxidant activity upon low density lipoprotein peroxidation. Biochem Pharmacol 48:487–494
  • Li PG, Xu JW, Ikeda K, Kobayakawa A, Kayano Y, Mitani T, Ikami T, Yamori Y. 2005. Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats. Hypertens Res 28:369–377
  • Ludwig IA, Clifford MN, Lean ME, Ashihara H, Crozier A. 2014. Coffee: biochemistry and potential impact on health. Food Funct. [Epub ahead of print]. doi: 10.1039/C4FO00042K
  • Maeztu L, Andueza S, Ibanez C, Paz de Pena M, Bello J, Cid C. 2001. Multivariate methods for characterization and classification of espresso coffees from different botanical varieties and types of roast by foam, taste, and mouthfeel. J Agric Food Chem 49:4743–4747
  • Martins SIFS, Jongen WMF, van Boekel MAJS. 2000. A review of Maillard reaction in food and implications to kinetic modelling. Trends Food Sci Technol 11:364–373
  • McCusker RR, Goldberger BA, Cone EJ. 2003. Caffeine content of specialty coffees. J Anal Toxicol 27:520–522
  • Meng S, Cao J, Feng Q, Peng J, Hu Y. 2013. Roles of chlorogenic acid on regulating glucose and lipids metabolism: a review. Evid Based Complement Alternat Med 2013:801457
  • Monnier VM, Sell DR, Dai Z, Nemet I, Collard F, Zhang J. 2008. The role of the amadori product in the complications of diabetes. Ann N Y Acad Sci 1126:81–88
  • Morales FJ, Somoza V, Fogliano V. 2012. Physiological relevance of dietary melanoidins. Amino Acids 42:1097–1109
  • Moreira AS, Nunes FM, Domingues MR, Coimbra MA. 2012. Coffee melanoidins: structures, mechanisms of formation and potential health impacts. Food Funct 3:903–915
  • Naidoo N, Chen C, Rebello SA, Speer K, Tai ES, Lee J, Buchmann S, et al. 2011. Cholesterol-raising diterpenes in types of coffee commonly consumed in Singapore, Indonesia and India and associations with blood lipids: a survey and cross sectional study. Nutr J 10:48
  • Nardini M, D'Aquino M, Tomassi G, Gentili V, Di Felice M, Scaccini C. 1995. Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Radic Biol Med 19:541–552
  • Narita Y, Inouye K. 2009. Kinetic analysis and mechanism on the inhibition of chlorogenic acid and its components against porcine pancreas alpha-amylase isozymes I and II. J Agric Food Chem 57:9218–9225
  • Natella F, Nardini M, Giannetti I, Dattilo C, Scaccini C. 2002. Coffee drinking influences plasma antioxidant capacity in humans. J Agric Food Chem 50:6211–6216
  • Neveu V, Perez-Jimenez J, Vos F, Crespy V, du Chaffaut L, Mennen L, Knox C, et al. 2010. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxford) 2010:bap024
  • Niseteo T, Komes D, Belscak-Cvitanovic A, Horzic D, Budec M. 2012. Bioactive composition and antioxidant potential of different commonly consumed coffee brews affected by their preparation technique and milk addition. Food Chem 134:1870–1877
  • Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. 2005. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 23:921–928
  • Nunes FM, Coimbra MA. 2007. Melanoidins from coffee infusions. Fractionation, chemical characterization, and effect of the degree of roast. J Agric Food Chem 55:3967–3977
  • Nunes FM, Coimbra MA. 2010. Role of hydroxycinnamates in coffee melanoidin formation. Phytochem Rev 9:171–195
  • O'Keefe JH, Bhatti SK, Patil HR, DiNicolantonio JJ, Lucan SC, Lavie CJ. 2013. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol 62:1043–1051
  • Ochiai R, Chikama A, Kataoka K, Tokimitsu I, Maekawa Y, Ohishi M, Rakugi H, Mikami H. 2009. Effects of hydroxyhydroquinone-reduced coffee on vasoreactivity and blood pressure. Hypertens Res 32:969–974
  • Olthof MR, Hollman PC, Katan MB. 2001. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 131:66–71
  • Ong KW, Hsu A, Tan BK. 2013. Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation. Biochem Pharmacol 85:1341–1351
  • Ozgen M, Reese RN, Tulio AZ Jr, Scheerens JC, Miller AR. 2006. Modified 2,2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (abts) method to measure antioxidant capacity of Selected small fruits and comparison to ferric reducing antioxidant power (FRAP) and 2,2′-diphenyl-1-picrylhydrazyl (DPPH) methods. J Agric Food Chem 54:1151–1157
  • Pacetti D, Boselli E, Balzano M, Frega NG. 2012. Authentication of Italian Espresso coffee blends through the GC peak ratio between kahweol and 16-O-methylcafestol. Food Chem 135:1569–1574
  • Parliament TH, Stahl HB. 2005. What makes the coffee smell so good? Chem Tech 25:38–47
  • Parras P, Martínez-Tomé M, Jimenez AM, Murcia MA. 2007. Antioxidant capacity of coffees of several origins brewed following three different procedures. Food Chem 102:582–592
  • Piazzon A, Vrhovsek U, Masuero D, Mattivi F, Mandoj F, Nardini M. 2012. Antioxidant activity of phenolic acids and their metabolites: synthesis and antioxidant properties of the sulfate derivatives of ferulic and caffeic acids and of the acyl glucuronide of ferulic acid. J Agric Food Chem 60:12312–12323
  • Porkka-Heiskanen T, Zitting KM, Wigren HK. 2013. Sleep, its regulation and possible mechanisms of sleep disturbances. Acta Physiol (Oxf) 208:311–328
  • Pulido R, Hernandez-Garcia M, Saura-Calixto F. 2003. Contribution of beverages to the intake of lipophilic and hydrophilic antioxidants in the Spanish diet. Eur J Clin Nutr 57:1275–1282
  • Richelle M, Tavazzi I, Offord E. 2001. Comparison of the antioxidant activity of commonly consumed polyphenolic beverages (coffee, cocoa, and tea) prepared per cup serving. J Agric Food Chem 49:3438–3442
  • Riordan J. 2003. Angiotensin-I-converting enzyme and its relatives. Genome Biol 4:225.221–225.225
  • Robertson D, Wade D, Workman R, Woosley RL, Oates JA. 1981. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 67:1111–1117
  • Rodriguez de Sotillo DV, Hadley M. 2002. Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem 13:717–726
  • Rodriguez de Sotillo DV, Hadley M, Sotillo JE. 2006. Insulin receptor exon 11+/− is expressed in Zucker (fa/fa) rats, and chlorogenic acid modifies their plasma insulin and liver protein and DNA. J Nutr Biochem 17:63–71
  • Rubayiza AB, Meurens M. 2005. Chemical discrimination of arabica and robusta coffees by Fourier transform Raman spectroscopy. J Agric Food Chem 53:4654–4659
  • Rufian-Henares JA, Morales FJ. 2007a. Angiotensin-I converting enzyme inhibitory activity of coffee melanoidins. J Agric Food Chem 55:1480–1485
  • Rufian-Henares JA, Morales FJ. 2007b. Effect of in vitro enzymatic digestion on antioxidant activity of coffee melanoidins and fractions. J Agric Food Chem 55:10016–10021
  • Rufián-Henares JA, Morales FJ. 2007c. Functional properties of melanoidins: in vitro antioxidant, antimicrobial and antihypertensive activities. Food Res Int 40:995–1002
  • Rustan AC, Halvorsen B, Huggett AC, Ranheim T, Drevon CA. 1997. Effect of coffee lipids (cafestol and kahweol) on regulation of cholesterol metabolism in HepG2 cells. Arterioscler Thromb Vasc Biol 17:2140–2149
  • Sacchetti G, Mattia CD, Pittia P, Mastrocola D. 2009. Effect of roasting degree, equivalent thermal effect and coffee type on the radical scavenging activity of coffee brews and their phenolic fraction. J Food Eng 90:74–80
  • Salinas-Vargas ME, Canizares-Macias MP. 2014. On-line solid-phase extraction using a C(1)(8) minicolumn coupled to a flow injection system for determination of caffeine in green and roasted coffee beans. Food Chem 147:182–188
  • Salomone F, Li Volti G, Vitaglione P, Morisco F, Fogliano V, Zappala A, Palmigiano A, et al. 2013. Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease. Transl Res 163:593–602
  • Shearer J, Farah A, de Paulis T, Bracy DP, Pencek RR, Graham TE, Wasserman DH. 2003. Quinides of roasted coffee enhance insulin action in conscious rats. J Nutr 133:3529–3532
  • Somoza V. 2005. Five years of research on health risks and benefits of Maillard reaction products: an update. Mol Nutr Food Res 49:663–672
  • Spiller MA. 1984. The chemical components of coffee. Prog Clin Biol Res 158:91–147
  • Spyroulias GA, Galanis AS, Pairas G, Manessi-Zoupa E, Cordopatis P. 2004. Structural features of angiotensin-I converting enzyme catalytic sites: conformational studies in solution, homology models and comparison with other zinc metallopeptidases. Curr Top Med Chem 4:403–429
  • Stalmach A, Mullen W, Barron D, Uchida K, Yokota T, Cavin C, Steiling H, et al. 2009. Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption. Drug Metab Dispos 37:1749–1758
  • Stalmach A, Steiling H, Williamson G, Crozier A. 2010. Bioavailability of chlorogenic acids following acute ingestion of coffee by humans with an ileostomy. Arch Biochem Biophys 501:98–105
  • Suzuki A, Fujii A, Yamamoto N, Yamamoto M, Ohminami H, Kameyama A, Shibuya Y, et al. 2006a. Improvement of hypertension and vascular dysfunction by hydroxyhydroquinone-free coffee in a genetic model of hypertension. FEBS Lett 580:2317–2322
  • Suzuki A, Kagawa D, Fujii A, Ochiai R, Tokimitsu I, Saito I. 2002a. Short- and long-term effects of ferulic acid on blood pressure in spontaneously hypertensive rats. Am J Hypertens 15:351–357
  • Suzuki A, Kagawa D, Ochiai R, Tokimitsu I, Saito I. 2002b. Green coffee bean extract and its metabolites have a hypotensive effect in spontaneously hypertensive rats. Hypertens Res 25:99–107
  • Suzuki A, Yamamoto M, Jokura H, Fujii A, Tokimitsu I, Hase T, Saito I. 2007. Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats. Am J Hypertens 20:508–513
  • Suzuki A, Yamamoto N, Jokura H, Yamamoto M, Fujii A, Tokimitsu I, Saito I. 2006b. Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats. J Hypertens 24:1065–1073
  • Svilaas A, Sakhi AK, Andersen LF, Svilaas T, Strom EC, Jacobs DR Jr, Ose L, Blomhoff R. 2004. Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 134:562–567
  • Tagliazucchi D, Verzelloni E, Conte A. 2010. Effect of dietary melanoidins on lipid peroxidation during simulated gastric digestion: their possible role in the prevention of oxidative damage. J Agric Food Chem 58:2513–2519
  • Teekachunhatean S, Tosri N, Rojanasthien N, Srichairatanakool S, Sangdee C. 2013. Pharmacokinetics of caffeine following a single administration of coffee enema versus oral coffee consumption in healthy male subjects. ISRN Pharmacol 2013:147238
  • Thelle DS. 1987. Coffee and cholesterol. A survey of published epidemiological and experimental studies. Tidsskr Nor Laegeforen 107:2429–2430
  • Umemura T, Ueda K, Nishioka K, Hidaka T, Takemoto H, Nakamura S, Jitsuiki D, et al. 2006. Effects of acute administration of caffeine on vascular function. Am J Cardiol 98:1538–1541
  • Urgert R, Katan MB. 1997. The cholesterol-raising factor from coffee beans. Annu Rev Nutr 17:305–324
  • van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ, van Dam RM. 2009. Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 32:1023–1025
  • van Rooij J, van der Stegen GH, Schoemaker RC, Kroon C, Burggraaf J, Hollaar L, Vroon TF, et al. 1995. A placebo-controlled parallel study of the effect of two types of coffee oil on serum lipids and transaminases: identification of chemical substances involved in the cholesterol-raising effect of coffee. Am J Clin Nutr 61:1277–1283
  • Variyar PS, Ahmad R, Bhat R, Niyas Z, Sharma A. 2003. Flavoring components of raw monsooned arabica coffee and their changes during radiation processing. J Agric Food Chem 51:7945–7950
  • Verzelloni E, Pellacani C, Tagliazucchi D, Tagliaferri S, Calani L, Costa LG, Brighenti F, et al. 2011a. Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites. Mol Nutr Food Res 55:S35–S43
  • Verzelloni E, Tagliazucchi D, Del Rio D, Calani D, Conte A. 2011b. Antiglycative and antioxidative properties of coffee fractions. Food Chem 124:1430–1435
  • Viana AL, Fonseca M, Meireles EL, Duarte SM, Rodrigues MR, Paula FB. 2012. Effects of the consumption of caffeinated and decaffeinated instant coffee beverages on oxidative stress induced by strenuous exercise in rats. Plant Foods Hum Nutr 67:82–87
  • Vinson JA, Proch J, Bose P, Muchler S, Taffera P, Shuta D, Samman N, Agbor GA. 2006. Chocolate is a powerful ex vivo and in vivo antioxidant, an antiatherosclerotic agent in an animal model, and a significant contributor to antioxidants in the European and American Diets. J Agric Food Chem 54:8071–8076
  • Vistoli G, De Maddis D, Cipak A, Zarkovic N, Carini M, Aldini G. 2013. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res 47:3–27
  • Vitaglione P, Morisco F, Mazzone G, Amoruso DC, Ribecco MT, Romano A, Fogliano V, et al. 2010. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 52:1652–1661
  • Wang H-Y, Qian H, Yao W-R. 2011. Melanoidins produced by the Maillard reaction: structure and biological activity. Food Chem 128:573–584
  • Watanabe C, Yamamoto H, Hirano K, Kobayashi S, Kanaide H. 1992. Mechanisms of caffeine-induced contraction and relaxation of rat aortic smooth muscle. J Physiol 456:193–213
  • Watanabe T, Arai Y, Mitsui Y, Kusaura T, Okawa W, Kajihara Y, Saito I. 2006. The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clin Exp Hypertens 28:439–449
  • Welsch CA, Lachance PA, Wasserman BP. 1989. Dietary phenolic compounds: inhibition of Na+-dependent D-glucose uptake in rat intestinal brush border membrane vesicles. J Nutr 119:1698–1704
  • Yamaguchi T, Chikama A, Mori K, Watanabe T, Shioya Y, Katsuragi Y, Tokimitsu I. 2008. Hydroxyhydroquinone-free coffee: a double-blind, randomized controlled dose-response study of blood pressure. Nutr Metab Cardiovasc Dis 18:408–414
  • Yeh CT, Yen GC. 2003. Effects of phenolic acids on human phenolsulfotransferases in relation to their antioxidant activity. J Agric Food Chem 51:1474–1479
  • Yoshinari O, Igarashi K. 2010. Anti-diabetic effect of trigonelline and nicotinic acid, on KK-A(y) mice. Curr Med Chem 17:2196–2202
  • Yoshinari O, Sato H, Igarashi K. 2009. Anti-diabetic effects of pumpkin and its components, trigonelline and nicotinic acid, on Goto-Kakizaki rats. Biosci Biotechnol Biochem 73:1033–1041
  • Yukawa GS, Mune M, Otani H, Tone Y, Liang XM, Iwahashi H, Sakamoto W. 2004. Effects of coffee consumption on oxidative susceptibility of low-density lipoproteins and serum lipid levels in humans. Biochemistry (Mosc) 69:70–74
  • Yuksel Z, Avci E, Erdem YK. 2010. Characterization of binding interactions between green tea flavonoids and milk proteins. Food Chem 121:450–456
  • Zhang R, Xu X, Chen T, Li L, Rao P. 2000. An assay for angiotensin-converting enzyme using capillary zone electrophoresis. Anal Biochem 280:286–290
  • Zhao Y, Wang J, Ballevre O, Luo H, Zhang W. 2012. Antihypertensive effects and mechanisms of chlorogenic acids. Hypertens Res 35:370–374
  • Zhou J, Chan L, Zhou S. 2012. Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease. Curr Med Chem 19:3523–3531
  • Zhou J, Zhou S, Zeng S. 2013. Experimental diabetes treated with trigonelline: effect on beta cell and pancreatic oxidative parameters. Fundam Clin Pharmacol 27:279–287

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.